INOZYME PHARMA, INC. Total Assets
INOZYME PHARMA, INC. had Total Assets of $95.16 million as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2025-05-14
- 2025-03-31: Assets $95.16M.
- 2024-12-31: Assets $123.18M.
- 2024-09-30: Assets $143.36M.
- 2024-06-30: Assets $155.71M.
| Period end | Assets |
|---|---|
| 2025-03-31 | $95.16M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $123.18M 10-Q · filed 2025-05-14 |
| 2024-09-30 | $143.36M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $155.71M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $176.94M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $200.85M 10-K · filed 2025-03-10 |
| 2023-09-30 | $205.70M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $150.93M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $141.80M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $139.19M 10-K · filed 2024-03-12 |
| 2022-09-30 | $154.02M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $161.99M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $108.93M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $123.54M 10-K · filed 2023-03-22 |
| 2021-09-30 | $137.75M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $148.26M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $158.91M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $169.36M 10-K · filed 2022-03-15 |
| 2020-09-30 | $178.99M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $68.51M 10-Q · filed 2020-09-03 |
| 2019-12-31 | $47.94M 10-K · filed 2021-03-25 |